NuvaRing Lawsuits Involving Blood Clots, Deep Vein Thrombosis, Pulmonary Embolism, & Strokes Being Evaluated By Alonso Krangle LLP

Court records indicate that NuvaRing lawsuits pending in state and federal courts will begin going to trial this spring.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
If you have developed serious side effects due to using NuvaRing, contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

If you have developed serious side effects due to using NuvaRing, contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

If you have developed serious side effects due to using NuvaRing, contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

Melville, NY (PRWEB) March 06, 2013

Alonso Krangle LLP, a law firm focused on fighting for the rights of victims of harmful drug side effects, is investigating NuvaRing lawsuits on behalf of women who allegedly suffered life-threatening NuvaRing blood clots and other serious NuvaRing side effects. According to the firm, NuvaRing lawsuits currently pending in both state and federal courts will begin going to trial in the coming months. Alonso Krangle is currently offering free consultations to victims of alleged NuvaRing side effects, including:

Venous thromboembolism (blood clots)
Deep vein thrombosis
Pulmonary embolism
Strokes
Wrongful death

Alonso Krangle LLP is already representing alleged victims of NuvaRing side effects in a consolidated litigation now underway in New Jersey Superior Court, Bergen County. Court records indicate that Superior Court Judge Brian R. Martinotti has scheduled the litigation’s first trial for May 2013. (In Re: NuvaRing Litigation, BER-L-3081-09). To discuss a potential claim with one of the experienced and compassionate NuvaRing lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

Brought to market in 2001, NuvaRing is a hormonal contraceptive device that releases a combination of etonogestrel, a synthetic progestin, and the estrogen, ethinyl estradiol. The small, flexible ring is designed to be inserted into the vagina once a month, and is kept in place for three weeks. Since its launch on the market, a number of studies have found an association between NuvaRing and serious side effects, including blood clots, deep vein thrombosis, pulmonary embolism, and strokes. For example, research released by the U.S. Food & Drug Administration (FDA) in 2011 showed that women who used NuvaRing faced a 56% increased risk of having a serious blood clot compared to those using older birth control pills. Last June, a study published in The New England Journal of Medicine found that women who used combined hormonal devices, such as NuvaRing, were 2.5 to 3 times more likely to experience strokes compared to women who used other types of hormonal birth control. A study published a month earlier in the British Medical Journal found the likelihood of NuvaRing users experiencing a dangerous blood clot was 90% higher than it was for women taking combined oral contraceptives containing levonorgestrel.
[fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf]
[nejm.org/doi/full/10.1056/NEJMoa1111840?query=featured_home]
[bmj.com/content/344/bmj.e2990]

Court records indicate that some 200 NuvaRing lawsuits are pending in the New Jersey litigation. Another 1,000 NuvaRing injury lawsuits have been filed in a federal multidistrict litigation underway in U.S. District Court, Northern District of Missouri. The Court has scheduled the first bellwether trial in the federal NuvaRing litigation for July 8, 2013. (In Re: NuvaRing Products Liability Litigation, MDL No. 1964)

There is still time for alleged victims of NuvaRing side effects to seek compensation for their injuries. To discuss a potential NuvaRing lawsuit with one of the experienced and compassionate drug injury attorneys at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website http://www.FightForVictims.com.

About Alonso Krangle LLP
Andres Alonso and David Krangle, attorneys with almost 40 years of collective legal experience, have focused their law practice on the handling of significant personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical negligence, qui tam/whistleblower actions and consumer fraud cases. A national law firm representing injured victims throughout the U.S., Alonso Krangle LLP is headquartered in Long Island, New York, with offices in New York City, and New Jersey.
For more information about Alonso Krangle or to join the fight and be a part of our team, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com

Contact: Alonso Krangle LLP
445 Broad Hollow Road
Suite 205
Melville, New York
11747
Toll-FREE 1-800-403-6191
Tel: 516-350-5555
Fax: 516-350-5554


Contact